Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Minority Interest: 2022-2024

Historic Minority Interest for Gyre Therapeutics (GYRE) over the last 3 years, with Dec 2024 value amounting to $35.1 million.

  • Gyre Therapeutics' Minority Interest rose 0.57% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year increase of 0.57%. This contributed to the annual value of $35.1 million for FY2024, which is 17.82% up from last year.
  • Per Gyre Therapeutics' latest filing, its Minority Interest stood at $35.1 million for FY2024, which was up 17.82% from $29.8 million recorded in FY2023.
  • Over the past 5 years, Gyre Therapeutics' Minority Interest peaked at $35.1 million during FY2024, and registered a low of $29.7 million during FY2022.
  • For the 3-year period, Gyre Therapeutics' Minority Interest averaged around $31.5 million, with its median value being $29.8 million (2023).
  • Data for Gyre Therapeutics' Minority Interest shows a peak YoY climbed of 17.82% (in 2024) over the last 5 years.
  • Over the past 3 years, Gyre Therapeutics' Minority Interest (Yearly) stood at $29.7 million in 2022, then grew by 0.28% to $29.8 million in 2023, then rose by 17.82% to $35.1 million in 2024.